Drug class in one race
Adenosine A2b receptor drugs for Non-Small Cell Lung Cancer
2 tracked Adenosine A2b receptor drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the Adenosine A2b receptor page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 1
Head-to-head evidence: PBF-1129 vs TT-4